Cancer drug could help women with metastatic breast cancer live longer, study says l GMA

A new study published in the New England Journal of Medicine says treating HER2-negative breast cancer patients with the existing cancer drug, Enhertu, can elongate their lives by five or six months.
READ MORE: https://gma.abc/3aLwMDc


SUBSCRIBE to GMA's YouTube page:
https://bit.ly/2Zq0dU5

SIGN UP to get the daily GMA Wake-Up Newsletter:
https://gma.abc/2Vzcd5j

VISIT GMA's homepage:
https://www.goodmorningamerica.com

FOLLOW GMA:
TikTok: https://tiktok.com/@gma
Instagram: https://instagram.com/GoodMorningAmerica
Facebook: https://facebook.com/GoodMorningAmerica
Twitter: https://twitter.com/gma


#GMA #BreastCancer #Enhertu #Medicine #chemotherapy